Abstract
The preparation of a water-soluble conjugate of mitomycin C (MMC) with N-succinyl-chitosan (Suc) by direct carbodiimide coupling was attempted. Smaller amounts of EDC, more advanced succinylated Suc (Suc(II)) and a shorter coupling reaction time were selected as reaction conditions. Almost half the obtained conjugate was water-soluble. The water-soluble conjugate, named Suc(II)-MMC, showed a high drug content of more than 10% (w/w). Suc(II)-MMC exhibited pH-dependent drug release, i.e. MMC release rate constants at 37°C were 0.007, 0.018 and 0.114 (h-1) at pH 6.2, 7.4 and 9.0, respectively. The addition of mouse plasma barely accelerated the release of MMC. Suc(II)-MMC was very stable at low temperatures (7°C), but showed gel-formation when left to stand at that temperature for 2 weeks. Gel- formation was not observed during standard in vitro and in vivo operations. Suc(II)-MMC showed less toxicity than MMC and a strong in vivo antitumor effect against Sarcoma 180 when administered IV at a high dose. MMC disappeared quickly from the systemic circulation after IV administration, while Suc(II)-MMC was retained at a high concentration of more than 15% of the dose/ml in plasma, even 8 h after IV administration.
Original language | English (US) |
---|---|
Pages (from-to) | 133-142 |
Number of pages | 10 |
Journal | S.T.P. Pharma Sciences |
Volume | 10 |
Issue number | 2 |
State | Published - Mar 2000 |
Externally published | Yes |
Keywords
- Antitumor characteristics
- High drug content
- N-succinyl-chitosan-mitomycin C
- pH-dependent drug release
- Systemic retention
- Water-soluble conjugate
ASJC Scopus subject areas
- Pharmaceutical Science